| 330 |
Vancomycin
|
-
Vancomycin, CAS-RN: 1404-90-6, DTXSID0042664
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 331 |
Polymyxin B
|
-
Polymyxin B, CAS-RN: 1404-26-8, DTXSID1048467
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 332 |
Colistin
|
-
Colistin, CAS-RN: 1066-17-7, DTXSID1040663
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 333 |
Albumin
|
-
Albumin, CAS-RN: 308060-74-4, DTXSID1040409
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 616 |
TAK-242
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 334 |
low molecular weight proteins
|
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 336 |
Acrylamide
|
-
Acrylamide, CAS-RN: 79-06-1, DTXSID5020027
|
17: Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
|
| 612 |
curcumin
|
-
Curcumin, CAS-RN: 458-37-7, DTXSID8031077
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 340 |
Methoxyacetic acid
|
-
Methoxyacetic acid, CAS-RN: 625-45-6, DTXSID1031591
|
212: Histone deacetylase inhibition leading to testicular atrophy
|
| 611 |
Pralnacasan (VX-740, HMR3480)
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 351 |
Halothane
|
-
Halothane, CAS-RN: 151-67-7, DTXSID4025371
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 358 |
Isoniazid
|
-
Isoniazid, CAS-RN: 54-85-3, DTXSID8020755
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 357 |
Titanium oxide (TiO)
|
-
Titanium oxide (TiO), CAS-RN: 12137-20-1, DTXSID7065253
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 600 |
Pentachlorophenol
|
-
Pentachlorophenol, CAS-RN: 87-86-5, DTXSID7021106
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 356 |
Chlorzoxazone
|
-
Chlorzoxazone, CAS-RN: 95-25-0, DTXSID9022813
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 601 |
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 355 |
Chemical:584015 (1-~13~C)Aniline
|
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 354 |
Sevoflurane
|
-
Sevoflurane, CAS-RN: 28523-86-6, DTXSID8046614
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 353 |
Methoxyflurane
|
-
Methoxyflurane, CAS-RN: 76-38-0, DTXSID7025556
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 352 |
Isoflurane
|
-
Isoflurane, CAS-RN: 26675-46-7, DTXSID3020752
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 344 |
Heptachlor
|
-
Heptachlor, CAS-RN: 76-44-8, DTXSID3020679
|
10: Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain
|
| 605 |
Emodin
|
-
Emodin, CAS-RN: 518-82-1, DTXSID5025231
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 609 |
Belnacasan (VX-765)
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 747 |
Toluene diisocyanate
|
-
Toluene diisocyanate, CAS-RN: 26471-62-5, DTXSID0024341
|
39: Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response
|
| 750 |
Iron nanoparticles
|
|
392: Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
|